🇺🇸 INOVIO PHARMACEUTICALS, INC.INO

Company Update Form 8-K 02-11-2026 07:15:10 EST

Subject: 8-K Items 7.01, 8.01, 9.01

Overview: FDA granted accelerated approval for VOCERYQ to reduce surgery frequency in adults with RRP, with commercial launch expected in Q1 2027.

Source: SEC EDGAR · Original filing

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest